Evidence map›Paper›PMID 34926660›Full record

ArticleAnnals of translational medicine2021

Tendon midsubstance trauma as a means for the development of translatable chronic rotator cuff degeneration in an ovine model.

James Johnson, Devin von Stade, Daniel Regan, Jeremiah Easley, Lyndah Chow, Steven Dow, Tony Romeo, Ted Schlegel, Kirk McGilvray

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Preclinical tendon and ligament models: Beyond the 3Rs (replacement, reduction, and refinement) to 5W1H (why, who, what, where, when, how).Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Review
  4. Animal model for tendinopathy.Journal of orthopaedic translation · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

James JohnsonOrthopaedic Bioengineering Research Laboratory, Colorado State University, Fort Collins, CO, USA.
Devin von StadeOrthopaedic Bioengineering Research Laboratory, Colorado State University, Fort Collins, CO, USA.
Daniel ReganDepartment of Microbiology, Immunology, & Pathology, Flint Animal Cancer Center, Fort Collins, CO, USA.
Jeremiah EasleyPreclinical Surgical Research Laboratory, Colorado State University, Fort Collins, CO, USA.
Lyndah ChowCenter for Immune and Regenerative Medicine, Department of Clinical Sciences, Colorado State University, Ft. Collins, CO, USA.
Steven DowDepartment of Microbiology, Immunology, & Pathology, Flint Animal Cancer Center, Fort Collins, CO, USA.
Tony RomeoRothman Orthopaedic Institute, New York, NY, USA.
Ted SchlegelDepartment of Orthopedics, University of Colorado School of Medicine, Aurora, CO, USA.
Kirk McGilvrayOrthopaedic Bioengineering Research Laboratory, Colorado State University, Fort Collins, CO, USA.
Colorado State University · USRothman Orthopaedics · USUniversity of Colorado Denver · US

Funding

Biomedical Research Training for VeterinariansT32OD010437 · OD · COLORADO STATE UNIVERSITY · PI Gregg A Dean, KELLY S SANTANGELO · 2012 to 2026
$6.2M
Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancerK01OD022982 · OD · COLORADO STATE UNIVERSITY · PI REGAN, DANIEL PATRICK · 2016 to 2021
$720k
NCATS NIH HHS L30 TR002126NIH HHS K01 OD022982NIH HHS T32 OD010437
6 · The paper itself

Abstract

backgroundChronic degeneration of rotator cuff tendons is a major contributing factor to the unacceptably high prevalence of rotator cuff repair surgery failures. The etiology of chronic rotator cuff degeneration is not well understood, and current therapies are not effective, necessitating preclinical research to fill this knowledge gap. Unfortunately, current large animal models rely on enthesis disruption as a means of model generation, which is not representative of human patients with chronic rotator cuff degeneration prior to full-thickness tears. Following, the goal of this study was to develop and characterize a translational large-animal model of chronic rotator cuff degeneration without enthesis release.

methodsA midsubstance damage model [i.e., "combed fenestration" (CF)] in adult sheep was generated by creating 16 longitudinal cuts within the top third of the infraspinatus tendon thickness. Tendon integrity was characterized through exhaustive non-destructive biomechanical stress relaxation testing [peak stress, peak load, percent relaxation, and cross-sectional area (CSA)], followed by histopathological degeneration scoring and analysis (Bonar score), histomorphological analysis of collagen organization and fatty atrophy (percent adipose area), and gene expression analyses.

resultsThe CF model tendons exhibited significantly decreased mechanical properties as evidenced by decreased peak stress (P<0.025) and increased percent relaxation (18-week

conclusionsThese data reveal that this new ovine CF model of chronic rotator cuff degeneration results in tendons with decreased mechanical properties, degenerative pathology characteristics, and gene expression profiles that aligned with the degenerative changes that have been noted in humans with tendinopathy. For these reasons, we believe this novel large animal model of chronic rotator cuff degeneration is a translational platform in which to test devices, therapies, and/or technologies aimed at repairing damage to the shoulder.

Indexed as

biomechanicschronic degenerationgene expressionhistopathologyRotator cuff

Identifiers

PMID34926660
PMCPMC8640899
OpenAlexW3207101423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.